There is an important unmet need to improve long term outcomes of encephalopathy for
preterm and term infants. Meta-analyses of large controlled trials suggest that maternal …

Objective Maternal exposure to magnesium sulphate has a neuroprotective effect in
premature infants. This study aimed to examine this neuroprotective effect and the dose …

Background Administration of magnesium sulphate (MgSO 4) to women with imminent
preterm birth at< 34 weeks is an evidence-based antenatal neuroprotective strategy to …

Background: Antenatal magnesium in preterm labor for neuroprotection decreases the
incidence of cerebral palsy. However, there are no guidelines on the dose and duration of …

Background There is widespread, increasing use of magnesium sulphate in obstetric
practice for pre-eclampsia, eclampsia, and preterm fetal neuroprotection; benefit for …

Magnesium is an intracellular cation essential for many en-zymatic processes and cellular
functions. Magnesium sulfate acts as an endogenous calcium channel antagonist at …

Health professionals at 25 A ustralian and N ew Z ealand tertiary maternity hospitals were
surveyed about local implementation of a clinical practice guideline for antenatal …

Preterm delivery (PTD) is a major cause of neonatal morbidity and mortality, with surviving
infants at risk for long-term neurologic sequelae. Although any birth occurring before the …

In a French randomized trial, children at school-age demonstrated no evidence of harm from
fetal exposure to MgSO 4 before very preterm birth. Motor dysfunction/death, qualitative …

OBJECTIVE: We sought to estimate the cost-effectiveness of magnesium neuroprophylaxis
for all women at risk for preterm birth< 32 weeks. STUDY DESIGN: A decision analytic and …